文献速递心外重症与机械循环支持

Impella 5.5对右心室负荷与适应的效应

Effects of Impella 5.5 on right ventricular load and adaptation.
PubMed 文献 · J Heart Lung Transplant · 2026-05-06

本研究回顾性纳入65例心源性休克患者,评估Impella 5.5支持对右心室血流动力学的纵向影响。结果显示填充压逐步下降,PVR与Ea改善,RVSWi与PAPi升高,RAP:PCWP稳定;23例桥接dLVAD患者中6例发生严重右心衰,Impella支持期间PAPi未能预测该事件。

要点

  • Impella 5.5支持后96小时内RAP从12降至9 mmHg,PCWP从26降至20 mmHg。
  • PVR与Ea改善,RVSWi与PAPi随时间升高,RAP:PCWP稳定。
  • Impella支持期间PAPi不能预测桥接dLVAD后严重右心衰。

核心结论

  • Impella 5.5支持与右心室负荷及适应的早期且持续改善相关。
  • Impella支持期间PAPi未预测dLVAD术后右心衰,提示其作为dLVAD前生理应激试验的效用有限。

研究设计与样本

  • 在基线、植入后即刻及至96小时的预设间隔收集系列有创血流动力学数据。

主要发现

  • 96小时时RAP从12降至9 mmHg,PCWP从26降至20 mmHg。
  • PVR与Ea改善,RVSWi与PAPi随时间增加。
  • RAP:PCWP保持稳定,血管活性正性肌力药物评分未升级。
  • 23例桥接dLVAD患者中6例按INTERMACS 2020标准发生严重dLVAD后右心衰。
  • Impella支持期间PAPi在发生与未发生右心衰的患者间无显著差异。

临床怎么用

  • Impella 5.5可改善心源性休克患者的右心室负荷与适应指标。
  • 不宜仅依据Impella支持期间的PAPi来预判dLVAD术后右心衰风险。

局限性

  • 单中心回顾性设计,样本量65例。
  • 桥接dLVAD并发生右心衰的病例数较少(6例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Impella 5.5 is increasingly used as a bridge to durable left ventricular assist device (dLVAD) implantation or heart transplantation, yet its effects on right ventricular (RV) hemodynamics remain incompletely characterized. We sought to evaluate the longitudinal effects of Impella 5.5 support on RV load and adaptation. METHODS: We retrospectively identified 65 patients with cardiogenic shock who received Impella 5.5 support at a single center between October 2020 and March 2024. Serial invasive hemodynamics were collected at baseline, immediately post-implant, and at predefined intervals through 96 hours. RV load was assessed using pulmonary vascular resistance (PVR) and pulmonary effective arterial elastance (Ea). RV adaptation was evaluated using RV stroke work index (RVSWi), pulmonary artery pulsatility index (PAPi), and RAP:PCWP ratio. RESULTS: Following Impella 5.5 implantation, filling pressures declined progressively, with RAP decreasing from 12 to 9 mmHg and PCWP from 26 to 20 mmHg at 96 hours. PVR and Ea improved, while RVSWi and PAPi increased over time. RAP:PCWP remained stable and vasoactive inotrope scores did not escalate. Among 23 patients bridged to dLVAD, 6 developed severe post-dLVAD RV failure by INTERMACS 2020 criteria. PAPi during Impella support did not differ significantly between those who did and did not develop RV failure. CONCLUSION: Impella 5.5 support is associated with early and sustained improvements in RV load and adaptation. PAPi during Impella support did not predict post-dLVAD RV failure, suggesting limited utility of the Impella 5.5 as a physiologic stress test prior to dLVAD implantation.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Silkowski MK, Olson A, Asempah M, et al. Effects of Impella 5.5 on right ventricular load and adaptation. J Heart Lung Transplant. 2026. PMID: 42103025. doi:10.1016/j.healun.2026.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。